UPL Ltd. News and Updates

Name: Latest research reports of UPL Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: UPL Ltd.
Rating: 5
Author: Motilal Oswal

Keep track of all breaking news on UPL Ltd. from all sources in a single place.

Load latest

UPL Ltd.

24 Jan 2019

695.40

-2.82%

Road clear for UPL to buy Arysta LifeScience

Business Line

UPL has received all regulatory approvals for the acquisition of Arysta LifeScience Inc and its subsidiaries from Platform Speciality Products Corpora

Number of FII/FPI investors increased from 798 to 851 in Jun 2025 qtr.

UPL Ltd.

23 Jan 2019

695.40

-2.82%

UPL:Copper-based products on the radar in the EU

Buy: UPL Ltd.

Motilal Oswal

The EU has passed a regulation (effective from Jan'19) to minimize the use of copper in crop protection products. The new regulation states that the permissible use of phy to sanitary products (pesticides, nematicides and rodenticides) containing copper compounds should be curbed. In this report, we analyze details of the regulation and its impact from UPLL's point of view.

UPL Ltd.'s price crossed below 30Day SMA today

UPL Ltd.

10 Jan 2019

695.40

-2.82%

UNITED PHOSPHORUS

Hold: UPL Ltd.

Recommendation Target

Geojit BNP Paribas

LATAM drives revenue growth; steady volume growth Revenue rose by 13% YoY in Q2FY19 led by strong performance in India and LATAM businesses (contributing around 66% of total sales). LATAM business registered a strong revenue growth of 26% YoY in Q2FY19 led by decent growth across geographies in the region especially Brazil barring Argentina which was impacted by currency depreciation and overall economic situation. LATAM's revenue contribution has increased to 41% during the quarter from 37% in Q2FY18. Management expects strong performance to continue in LATAM in H2FY19 as well led by advance orders received in Brazil. Going ahead, we expect LATAM revenue to grow at a CAGR of 13% over FY18-20E on the back of strong...

UPL Ltd. is trading below its 30 day SMA of 709.2

UPL Ltd.

27 Dec 2018

695.40

-2.82%

Challenges begin to emerge for UPL Arysta combine

livemint

UPL is expected to continue to account for the Arysta acquisition-related expenses, which had slowed profit growth last quarter

Deven Choksey increased Accumulate price target of UPL Ltd. to 749.0 on 03 Sep, 2025.

UPL Ltd.

18 Dec 2018

695.40

-2.82%

UPL faces near-term growth headwinds over European concerns, Arysta buy

Business Standard

After a 24 per cent run-up on the bourses from its October low, the stock of UPL fell about three per cent on Tuesday. Fresh concern on European growth (due to grought there) has the Street worried at the agrochemicals and industrial chemicals entityEuropean sales have been sluggish for most of this year and after completion of the acquisition of Arysta, its dependence on Europe is expected to increase. The region contributed about 24 per cent to UPL's sales in 2017-18.Analysts see an impact on demand for fungicide in Europe, given lower rainfall and higher temperatures, leading to fewer attacks of fungus. They also see some pricing pressure for UPL's products. Analysts at CIMB say the company faces volume and pricing risk for Mancozeb, a fungicide. Over the past few years, significant incremental revenue in UPL's agrochemical division was derived from Mancozeb. The molecule is now up against new formulations from Bayer and DowDuPont, which are under patent periods. Hence, UPL could .

Number of FII/FPI investors increased from 798 to 851 in Jun 2025 qtr.

UPL Ltd.

18 Dec 2018

695.40

-2.82%

Europe drought negative for UPL, says CIMB

Economic Times

CIMB said rainfall in Europe is at a multi-year low and heatwaves are prevalent.

Deven Choksey increased Accumulate price target of UPL Ltd. to 749.0 on 03 Sep, 2025.

UPL Ltd.

06 Dec 2018

695.40

-2.82%

UPL CEO to lead Arysta operations

Business Line

UPL Ltd, an agro-chemical company, has appointed a new executive team under Jai Shroff, its current Global CEO, to lead operations post completion

Deven Choksey increased Accumulate price target of UPL Ltd. to 749.0 on 03 Sep, 2025.

UPL Ltd.

02 Dec 2018

695.40

-2.82%

UPL

Hold: UPL Ltd.

Recommendation Target

Sharekhan

Scales higher in the top five league globally: With Arysta's acquisition, UPL moves ahead in the global agri-chemical ranking and is now among the top five players. The acquisition is expected to provide significant benefits to UPL, as it complements UPL in many areas. Arysta is an asset-light company and a global provider of innovative crop-protection solutions, including...

UPL Ltd. is trading above its 200 day SMA of 627.3

UPL Ltd.

02 Dec 2018

695.40

-2.82%

UPL

Hold: UPL Ltd.

Recommendation Target

Sharekhan

Deven Choksey increased Accumulate price target of UPL Ltd. to 749.0 on 03 Sep, 2025.

UPL Ltd.

27 Nov 2018

695.40

-2.82%

Set to play in the big league

Buy: UPL Ltd.

Motilal Oswal

In Brazil, UPLL primarily engages in soybean and maize (together account for 63% of the countrys total plantation area) and Arysta in sugarcane and cotton (19% of the countrys total plantation area). Moreover, UPLL has a strong presence in fungicides, while Arysta has a robust platform of bio solutions (#2 globally in bio stimulants) and seed treatment in Brazil. Brazilian farmers are enjoying strong demand for soybean, primarily due to the tense ties between the US and China. According to industry sources, China accounts for more than 60% of the soybean traded worldwide. This apart, Brazils producers are selling soybean at a premium soybean that were to be loaded in August fetched USD2.21/bushel more than Chicago futures as on July first week the widest gap since 2014. Where Unizeb Gold (brand of mancozeb) is sold at ~USD4 per unit in Brazil, Tridium fetches a realization of USD8-10 per unit.